Squarepoint
IRMD icon

Squarepoint’s iRadimed IRMD Stock Holding History

Squarepoint’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14M Buy
13,208
+9,662
+272% +$868K ﹤0.01% 2666
2026
Q2 		$339K Sell
3,546
-843
-19% -$76.8K ﹤0.01% 3717
2026
Q1 		$422K Buy
+4,389
New +$439K ﹤0.01% 3432
2025
Q1 		– Sell
-15,764
Closed -$867K – 4996
2024
Q4 		$867K Buy
15,764
+4,591
+41% +$242K ﹤0.01% 3191
2024
Q3 		$562K Sell
11,173
-10,622
-49% -$490K ﹤0.01% 3008
2024
Q2 		$958K Buy
21,795
+9,343
+75% +$397K ﹤0.01% 2582
2024
Q1 		$548K Buy
+12,452
New +$550K ﹤0.01% 2981
2020
Q2 		– Sell
-13,670
Closed -$292K – 2365
2020
Q1 		$292K Sell
13,670
-14,634
-52% -$348K 0.01% 1313
2019
Q4 		$662K Buy
28,304
+14,672
+108% +$343K ﹤0.01% 1595
2019
Q3 		$287K Buy
+13,632
New +$278K ﹤0.01% 1924

Other funds holding IRMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Squarepoint's IRMD Position: Q3 2026 in Review

Squarepoint increased its iRadimed (IRMD) stake by 272% in Q3 2026, buying an estimated $868K and bringing the position to 13,208 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Squarepoint first reported a position in IRMD in Q3 2019 and has held it in 10 quarters since. 157 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Squarepoint held 13,208 shares of iRadimed worth $1.14M as of Q3 2026.
  • Squarepoint bought 9,662 iRadimed shares in Q3 2026, an estimated $868K.
  • iRadimed made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2666 holding.
  • Squarepoint first reported a position in iRadimed in Q3 2019 and has held it in 10 quarters since.
  • 157 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.